“mpm-capital” Archives

in
Entry Author Date Location
Trivascular Obtains $40,000,000 Series E Funding Round 11/18/13 San Francisco
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
Sideris Pharmaceuticals Receives $32,000,000 Series A Funding 10/23/13 Boston
Mitokyne Garners $45,000,000 Series A Financing Round 10/21/13 Boston
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
iPierian Receives $30,000,000 New Funding Round 09/04/13 San Francisco
True North Therapeutics Garners Series A Funding 09/04/13 San Francisco
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Syndax Pharmaceuticals Lands $26,600,000 Series B Financing 08/27/13 Boston
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
San Diego’s Conatus Pharmaceuticals Sets Price Range for IPO Shares 07/09/13 San Diego
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
East Coast Life Sciences Roundup: Bind, Gen9, Radius, Cydan 04/26/13 Boston
Radius Health Receives $43,000,000 New Round 04/26/13 Boston
Radius Health, Still Private, Raises Another $43M 04/25/13 Boston
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Nevro Obtains $48,000,000 Series C Funding Round 03/07/13 San Francisco
California Stem Cell Agency Shifts Focus to Clinical Treatments 01/31/13 San Francisco
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
23andMe Lands $50,000,000 Series D Funding 12/11/12 San Francisco
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
Astute Medical Receives $40,400,000 Series C Funding 06/07/12 San Diego
Trivascular Lands $60,000,000 Series D Funding Round 06/05/12 San Francisco
Page 2 of 8 « previous page · next page »